Last update :
03/05/2024
References   References 2256  
Type : Manufacturer

Research teams :
Authors :
Title : Stability of doxorubicin "Ebewe" infusion solutions.
Reference : Ebewe Pharma 2007

Level of Evidence : 
Manufacturer's stability data
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
InjectionDoxorubicin hydrochloride Anticancer drug
Factors which affect stability Concentration Reduction Induces Reduced stability
Stability in solutions Glass NaCl 0,9% or Glucose 5% 0,1 mg/ml 20-25°C With or without light
4 Day
Stability in solutions Glass NaCl 0,9% or Glucose 5% 0,1 & 1 mg/ml 2-8°C Protect from light
28 Day
Stability in solutions Glass NaCl 0,9% or Glucose 5% 1 mg/ml 20-25°C With or without light
28 Day
Stability in solutions Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,1 mg/ml 20-25°C With or without light
4 Day
Stability in solutions Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,1 & 1 mg/ml 2-8°C Protect from light
28 Day
Stability in solutions Polyvinyl chloride NaCl 0,9% or Glucose 5% 1 mg/ml 20-25°C With or without light
28 Day
Stability in solutions Polyethylene NaCl 0,9% or Glucose 5% 0,1 mg/ml 20-25°C With or without light
4 Day
Stability in solutions Polyethylene NaCl 0,9% or Glucose 5% 0,1 & 1 mg/ml 2-8°C Protect from light
28 Day
Stability in solutions Polyethylene NaCl 0,9% or Glucose 5% 1 mg/ml 20-25°C With or without light
28 Day
Stability in solutions Polypropylen Syringe NaCl 0,9% or Glucose 5% 0,1 mg/ml 20-25°C With or without light
4 Day
Stability in solutions Polypropylen Syringe NaCl 0,9% or Glucose 5% 0,1 & 1 mg/ml 2-8°C Protect from light
28 Day
Stability in solutions Polypropylen Syringe NaCl 0,9% or Glucose 5% 1 mg/ml 20-25°C With or without light
28 Day

  Mentions Légales